Read More 1 minute read FDA News READ: Full Study Titled ‘Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot’ By Benzinga Newsdesk Today, 7:57 PM https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1.full.pdf https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1 AZN
Read More 1 minute read FDA Hot News Pfizer Study Shows Bivalent Boosters Offer No Short-Term Superiority By Benzinga Newsdesk Today, 7:57 PM -Reuters AZN
Read More 5 minute read Markets Movers News Penny Stocks Pre-Market Outlook Small Cap Trading Ideas Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday By Lisa Levin Today, 7:57 PM Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. ALF
Read More 2 minute read Markets Movers News Penny Stocks Pre-Market Outlook Small Cap Trading Ideas Moderna, Amazon, Tesla, And Other Big Gainers From Friday By Lisa Levin Today, 7:57 PM U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session. AMZN
Read More 1 minute read Analyst Ratings Markets News Price Target Trading Ideas Amazon To $175? Plus JP Morgan Cuts Price Target On Meta Platforms By Lisa Levin Today, 7:57 PM JP Morgan cut the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $185 to $175. Amazon shares gained 2.2% to trade at $117.82 on Friday. AA
Read More 3 minute read Intraday Update Markets Movers News Penny Stocks Small Cap Trading Ideas Why Boston Beer Shares Are Trading Higher? Here Are 52 Stocks Moving In Friday’s Mid-Day Session By Lisa Levin Today, 7:57 PM Gainers Altamira Therapeutics Ltd. (NASDAQ: CYTO) surged 67% to $0.5484 after the company announced divestiture of its inner ear development assets. AMPX
Read More 13 minute read Analyst Ratings Downgrades Initiation Intraday Update Upgrades Benzinga’s Top Ratings Upgrades, Downgrades For October 21, 2022 By Benzinga Insights Today, 7:57 PM Upgrades ACI
Read More 1 minute read Analyst Ratings News Price Target Upgrades SVB Leerink Upgrades Moderna to Market Perform, Raises Price Target to $101 By Benzinga Newsdesk Today, 7:57 PM SVB Leerink analyst Mani Foroohar upgrades Moderna (NASDAQ:MRNA) from Underperform to Market Perform and raises the price target from $74 to $101. MRNA
Read More 1 minute read FDA News EU Commission Says Has Authorized Moderna’s Ba.4/ba.5 Adapted COVID Booster Vaccine Following The Opinion Of EMA By Benzinga Newsdesk Today, 7:57 PM -Reuters MRNA
Read More 1 minute read News CDC Advisers Recommend Adding Covid-19 Vaccines To Adult, Children’s Immunization Schedules By Benzinga Newsdesk Today, 7:57 PM - Dow Jones Citing WSJ AZN